Printer Friendly

SALVATORI OPHTHALMICS MAKES ANNOUNCEMENT REGARDING COMMON STOCK

 SALVATORI OPHTHALMICS MAKES ANNOUNCEMENT REGARDING COMMON STOCK
 SARASOTA, Fla., Aug. 18 /PRNewswire/ -- Salvatori Ophthalmics, Inc. announced today that its common stock was delisted from the NASDAQ system as of July 22, 1992. The company's stock continues to be traded on the over-the-counter market.
 The NASD Market Qualification Committee was of the opinion that the company "would not be in compliance with NASDAQ's capital and surplus and minimum bid price requirements within the foreseeable near future." The company, which signed a letter of intent to acquire G.T. Laboratories Inc. and Fused Kontacts of Chicago, Inc. on May 15, 1992, contended that the acquisition would bring the company into compliance with the NASDAQ standards.
 NASDAQ's rules permit this decision to be reviewed by the Review Committee. The company intends to seek review of this decision. However, the stock will not be listed on NASDAQ pending completion of the review.
 Salvatori Ophthalmics, Inc. is a manufacturer of soft contact lenses and solutions and rigid gas permeable lenses. It has offices and manufacturing facilities located at Sarasota, Fla., and Lincoln, Neb.
 -0- 8/18/92
 /CONTACT: David J. Dougherty or Joseph A. Arena of Salvatori Ophthalmics, Inc., 813-753-0383/ CO: Salvatori Ophthalmics, Inc. ST: Florida IN: MTC SU:


SS-AW -- FL011 -- 1112 08/18/92 17:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 18, 1992
Words:213
Previous Article:NEVADA POWER FIRST MORTGAGE BONDS, PREFERRED LOWERED TO 'BBB' BY FITCH -- FITCH FINANCIAL WIRE --
Next Article:JOHN NUVEEN COMPANY DECLARES INITIAL QUARTERLY DIVIDEND
Topics:


Related Articles
SALVATORI OPHTHALMICS COMPLETES $700,000 FINANCING WITH TULLIS-DICKERSON CAPITAL FOCUS, L.P.
SALVATORI OPHTHALMICS REPORTS 1991 THIRD QUARTER RESULTS OF OPERATIONS
SALVATORI OPHTHALMICS REPORTS RESULTS
SALVATORI OPHTHALMICS, INC. ANNOUNCES PROPOSED ACQUISITION OF G.T. LABORATORIES, INC. AND FUSED KONTACTS, INC.
SALVATORI OPHTHALMICS REPORTS 1992 SECOND QUARTER RESULTS OF OPERATIONS
SALVATORI OPHTHALMICS TALKS CONTINUING FOR ACQUISITION OF G.T. LABORATORIES AND FUSED KONTACTS, INC.
SALVATORI OPHTHALMICS ANNOUNCES APPOINTMENT OF JOSEPH A. ARENA AS CHIEF EXECUTIVE OFFICER
SALVATORI OPHTHALMICS REPORTS 1992 FIRST QUARTER RESULTS OF OPERATIONS
SALVATORI OPHTHALMICS REPORTS 1993 SECOND QUARTER RESULTS
SALVATORI NAMES ARENA

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters